Johnson & Johnson agrees on price with Actelion; talks focused on valuation of R&D unit proceeding

11/01/2017 22:18
  • According to sources close to the matter, Johnson & Johnson (NYSE:JNJ) has tentatively agreed on an acquisition price for Actelion Ltd. (OTCPK:ALIOY). The negotiations are now focused on valuing the new R&D unit.
  • More news on: Johnson & Johnson, Actelion Ltd. ADR, Healthcare stocks news, Merger & acquisition news,
  • Read more ...

More News

Whole Foods Market Announces First Quarter Earnings Conference Call and Webcast

11/01/2017 22:01

AUSTIN, Texas, Jan. 11, 2017 (GLOBE NEWSWIRE) -- Whole Foods Market (NASDAQ:WFM) today anno...

New Innovative In-home Treatment Program for Addiction Comes to New Hampshire

11/01/2017 21:17

Aware Recovery Care of NH to provide in-home, outpatient service options covered by Anthem...

Hubbell Power Systems, Inc. Announces New Changes in Sales Channel and Customer Service

11/01/2017 17:13

In support of its growth in the communications market, Hubbell Power Systems, Inc. (HPS) has...

Terms and Conditions | Privacy Statement is an educational platform. We DO NOT deal with securities and receive any financial benefits from Financial Products & Service Providers.